跳至主要内容
临床试验/NCT00910819
NCT00910819已完成不适用

Prospective and Retrospective Observation of the Adjuvant and Palliative Treatment Strategies in the Therapy of Colorectal Cancer in Germany

iOMEDICO AG1 个研究点 分布在 1 个国家目标入组 7,000 人开始时间: 2006年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
iOMEDICO AG
入组人数
7,000
试验地点
1
主要终点
Course of Antineoplastic Treatment

研究概览

简要总结

To describe treatment reality of patients with colorectal cancer treated by office-based and clinic-based medical oncologists in Germany.

详细描述

The TKK is a prospective, longitudinal, nation wide cohort study with the purpose to record information on the antineoplastic treatment of colorectal cancer in Germany. The registry will follow patients for up to five years. It will identify common therapeutic sequences and changes in the treatment of the disease. At inclusion, data in patient characteristics, comorbidities, tumor characteristics, biomarker testing and previous treatments are collected. During the course of observation data on all systemic treatments, radiotherapies, surgeries, and outcome are documented.

The impact of nutrition (CoNut) and physical activity (CoNut) on the course of the adjuvant disease will be examined, as well as long-term effects of adjuvant treatment (CoTox) and the final phase of the palliative process (CoLife). Based on the available data a prognostic score will be developed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Colorectal cancer
  • 18 years and older
  • Antineoplastic treatment

排除标准

  • No colorectal cancer
  • Below 18 years
  • No antineoplastic treatment

结局指标

主要结局

Course of Antineoplastic Treatment

时间窗: 5 years

次要结局

未报告次要终点

研究者

发起方
iOMEDICO AG
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验